Controlling Concrete Degradation || SPECIFICATIONS FOR MARITIME STRUCTURES -MYTHOLOGY OR METHODOLOGY?
- 作者Dhir, Ravindra K.; Newlands, Moray D.
- 文件大小902.93KB
- 发表时间1999
- DOI10.1680/ccd.28197.0004
- 页码45-59
Trends in Prevalence of Nonalcoholic Fatty Liver Disease in US Adults with PrediabetesLe, Phuc; Chaitoff, Alexander; Rothberg, Michael B.; Alkhouri, Naim; McCullough, Arthur · Journal of General Internal Medicine · 2019
Population-Based Trends in Prevalence of Nonalcoholic Fatty Liver Disease in U.S. Adults With Type 2 DiabetesLe, Phuc; Chaitoff, Alexander; Rothberg, Michael B.; Mccullough, Arthur; Gupta, Niyati M.; Alkhouri, Naim · Clinical Gastroenterology and Hepatology · 2018
Inhibitors of the anaplastic lymphoma kinaseMologni, Luca · Expert Opinion on Investigational Drugs · 2012
Melatonin in cardiovascular diseaseDominguez-Rodriguez, Alberto · Expert Opinion on Investigational Drugs · 2012
Drugs for bone healingBrandi, Maria Luisa · Expert Opinion on Investigational Drugs · 2012
Rheumatoid arthritis: developing pharmacological therapiesMoreland, Larry W; Misischia, Richard J · Expert Opinion on Investigational Drugs · 2002
New and investigational antiepileptic drugsStriano, Pasquale; Striano, Salvatore · Expert Opinion on Investigational Drugs · 2009
Ertapenem: a new carbapenemOdenholt, Inga · Expert Opinion on Investigational Drugs · 2001
Recent developments in carbapenemsNicoletti, Giuseppe; Russo, Giovanni; Bonfiglio, Giovanni · Expert Opinion on Investigational Drugs · 2002
The immunotherapeutic potential of melatoninMaestroni, Georges JM · Expert Opinion on Investigational Drugs · 2001